Core Viewpoint - UBS has upgraded China General Nuclear Power (01816) from "Sell" to "Neutral" due to its favorable position in accelerating the deployment of Small Modular Reactors (SMR) in China and potential benefits from advancements in nuclear fusion technology [1] Summary by Relevant Categories Company Positioning - China General Nuclear Power is well-positioned to benefit from the rapid deployment of SMR technology in China [1] - The company may also gain from breakthroughs in nuclear energy technology in the long term [1] Financial Outlook - UBS has raised the target price for China General Nuclear Power from HKD 2.3 to HKD 3.4, indicating a reasonable valuation with limited downside [1] - The cash flow discount rate used for valuation suggests that the current price reflects the company's financial health [1] Short-term Risks - UBS remains cautious about the short-term outlook for China General Nuclear Power, primarily due to risks associated with declining market electricity prices and rising uranium procurement costs [1] - The company is expected to face ongoing profit pressure until 2026, with earnings per share forecasts for 2025 to 2027 approximately 11% lower than market expectations [1]
瑞银：升中广核电力评级至“中性” 目标价上调至3.4港元